glp 1 and longevity GLP-1s: The world's first drug? Efficacy and longevity of the
Description
Individual response to GLP-1 medications varies
Notoriously, both GIPR agonists and antagonists lead to weight loss mainly when co-administrated with GLP-1 agonists or analogues (Killion et al
For researchers already on tirzepatide considering a switch, understanding the transition timeline from tirzepatide to retatrutide helps with budget planning, since there may be an overlap period during the switch
Frhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM
Neurobiol Aging (2012) 33(2):26576
